TABLE 3

The systemic AUCs, portal AUCs, and Fa·Fg of FEX (5 mg/kg), SASP (5 mg/kg), and TPT (0.3 mg/kg) after pretreatment with ZSQ (30 mg/kg) and/or Ko143 (10 mg/kg) in the portal vein–cannulated rats

SubstratePretreatmentAUCsysAUCporRbFa·Fg
ng·h/mlng·h/ml
FEXControl59.9 ± 40.9617 ± 4900.990.22 ± 0.18
ZSQ431 ± 63***2563 ± 286***0.84 ± 0.10***
Ko14355.0 ± 19.7‡‡‡565 ± 118‡‡‡0.20 ± 0.05‡‡‡
ZSQ + Ko143284 ± 39***##†††2243 ± 330***†††0.77 ± 0.13***†††
SASPControl366 ± 37499 ± 420.580.03 ± 0.01
ZSQ339 ± 29443 ± 320.02 ± 0.01
Ko1432881 ± 646***‡‡‡3492 ± 716***‡‡‡0.14 ± 0.07*‡
ZSQ + Ko1432529 ± 549***###3146 ± 411***###0.14 ± 0.04*#
TPTControl18.3 ± 1.630.9 ± 1.51.260.11 ± 0.03
ZSQ36.2 ± 13.763.8 ± 19.40.23 ± 0.07
Ko14369.0 ± 17.5**‡119 ± 18***‡‡0.42 ± 0.10*
ZSQ + Ko143122 ± 15***###†††200 ± 35***###†††0.64 ± 0.20***###
  • Values represent the mean ± S.D. for three to five rats. Statistically significant differences: *P < 0.05, **P < 0.01, ***P < 0.001, control versus ZSQ, Ko143, or ZSQ+Ko143; ‡P < 0.05, ‡‡P < 0.01, ‡‡‡P < 0.001, ZSQ versus Ko143; #P < 0.05; ##P < 0.01; ###P < 0.001, ZSQ versus ZSQ+Ko143; †††P < 0.001, Ko143 versus ZSQ+Ko143.